Leo Niskanen

31.0k total citations · 7 hit papers
347 papers, 22.9k citations indexed

About

Leo Niskanen is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Surgery. According to data from OpenAlex, Leo Niskanen has authored 347 papers receiving a total of 22.9k indexed citations (citations by other indexed papers that have themselves been cited), including 149 papers in Endocrinology, Diabetes and Metabolism, 71 papers in Physiology and 56 papers in Surgery. Recurrent topics in Leo Niskanen's work include Diabetes, Cardiovascular Risks, and Lipoproteins (44 papers), Diabetes Management and Research (41 papers) and Diabetes Treatment and Management (38 papers). Leo Niskanen is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (44 papers), Diabetes Management and Research (41 papers) and Diabetes Treatment and Management (38 papers). Leo Niskanen collaborates with scholars based in Finland, United States and Sweden. Leo Niskanen's co-authors include Matti Uusitupa, David E. Laaksonen, Jukka T. Salonen, Markku Laakso, Timo A. Lakka, Kari Punnonen, Kristiina Nyyssönen, Rainer Rauramaa, Onni Siitonen and Heimo Viinamäki and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Leo Niskanen

334 papers receiving 21.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1999 1.5k citations Leo Niskanen et al. profile →
Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study

2009 872 citations Arne Astrup, Stephan Rössner et al. profile →
11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)

2009 856 citations Leo Niskanen et al. profile →
Testosterone and Sex Hormone–Binding Globulin Predict the Metabolic Syndrome and Diabetes in Middle-Aged Men

2004 711 citations Leo Niskanen, Tomi‐Pekka Tuomainen et al. profile →
Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial

2013 606 citations Leo Niskanen et al. profile →
Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide

2011 536 citations Arne Astrup, Raffaele Carraro et al. profile →
Uric Acid Level as a Risk Factor for Cardiovascular and All-Cause Mortality in Middle-aged Men

2004 529 citations Leo Niskanen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Leo Niskanen Finland	78	9.4k	4.6k	4.5k	3.5k	3.2k	347	22.9k
Giuseppe Paolisso Italy	81	7.3k 0.8×	6.6k 1.4×	4.9k 1.1×	3.2k 0.9×	5.4k 1.7×	476	24.4k
Hans Lithell Sweden	79	7.3k 0.8×	4.9k 1.1×	7.5k 1.7×	2.7k 0.8×	2.7k 0.8×	360	21.8k
Anthony Barnett United Kingdom	76	9.1k 1.0×	4.7k 1.0×	1.9k 0.4×	4.4k 1.3×	4.1k 1.3×	391	23.5k
Robert J. Heine Netherlands	91	15.2k 1.6×	4.4k 0.9×	6.3k 1.4×	4.8k 1.4×	4.6k 1.5×	325	28.7k
Lynne E. Wagenknecht United States	79	8.1k 0.9×	5.2k 1.1×	4.9k 1.1×	3.3k 0.9×	3.2k 1.0×	336	22.2k
Tapani Rönnemaa Finland	80	8.7k 0.9×	4.1k 0.9×	8.6k 1.9×	5.0k 1.4×	3.5k 1.1×	392	26.7k
Hendrik Lehnert Germany	65	5.4k 0.6×	2.7k 0.6×	4.2k 0.9×	2.6k 0.7×	2.9k 0.9×	411	18.0k
Michael P. Stern United States	76	10.5k 1.1×	4.6k 1.0×	4.0k 0.9×	3.2k 0.9×	4.2k 1.3×	231	23.4k
Arya M. Sharma Canada	77	6.4k 0.7×	7.6k 1.6×	9.0k 2.0×	6.8k 2.0×	3.4k 1.1×	410	27.0k
Peter M. Nilsson Sweden	77	6.3k 0.7×	3.7k 0.8×	5.8k 1.3×	3.5k 1.0×	3.9k 1.2×	591	21.5k

Countries citing papers authored by Leo Niskanen

Since Specialization

Citations

This map shows the geographic impact of Leo Niskanen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leo Niskanen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leo Niskanen more than expected).

Fields of papers citing papers by Leo Niskanen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leo Niskanen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leo Niskanen. The network helps show where Leo Niskanen may publish in the future.

Co-authorship network of co-authors of Leo Niskanen

This figure shows the co-authorship network connecting the top 25 collaborators of Leo Niskanen. A scholar is included among the top collaborators of Leo Niskanen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leo Niskanen. Leo Niskanen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Niskanen, Leo, et al.. (2024). Renal Hyperfiltration as a New Mechanism of Smoking-Related Mortality. Nicotine & Tobacco Research. 27(6). 1092–1097.

Metsärinne, Kaj, Mikko Pietilä, Ilkka Kantola, et al.. (2023). Chronic kidney disease stage is associated with the number of risk factors in type 2 diabetes patients (STages Of NEphropathy in type 2 diabetes and Heart Failure – STONE HF). Primary care diabetes. 17(6). 632–638. 2 indexed citations

Metsärinne, Kaj, Mikko Pietilä, Ilkka Kantola, et al.. (2021). The majority of type 2 diabetic patients in Finnish primary care are at very high risk of cardiovascular events: A cross-sectional chart review study (STONE HF). Primary care diabetes. 16(1). 135–141. 4 indexed citations

Kacimi, Salah Eddine Oussama, et al.. (2021). Mortality-based definition of renal hyperfiltration in middle-aged men: a 35-year cohort from Finland. International Urology and Nephrology. 54(7). 1673–1680. 5 indexed citations

Voutilainen, Ari, et al.. (2021). Negative interaction of fatty liver and hypertension on cardiovascular mortality in non-diabetic men: 34 years of follow-up. Scandinavian Journal of Gastroenterology. 56(9). 1096–1102. 1 indexed citations

Tuomainen, Tomi‐Pekka, et al.. (2018). Follicle-stimulating hormone is associated with lipids in postmenopausal women. Menopause The Journal of The North American Menopause Society. 26(5). 540–545. 26 indexed citations

Bertone‐Johnson, Elizabeth R., Jyrki K. Virtanen, Leo Niskanen, et al.. (2017). Association of follicle-stimulating hormone levels and risk of type 2 diabetes in older postmenopausal women. Menopause The Journal of The North American Menopause Society. 24(7). 796–802. 24 indexed citations

Koskela, Heikki, Päivi Salonen, Jarkko Romppanen, & Leo Niskanen. (2014). Long-term mortality after community-acquired pneumonia—impacts of diabetes and newly discovered hyperglycaemia: a prospective, observational cohort study. BMJ Open. 4(8). e005715–e005715. 23 indexed citations

Villberg, Jari, Pauli Rintala, Mauno Vanhala, et al.. (2012). Perceived need to increase physical activity levels among adults at high risk of type 2 diabetes. A cross-sectional analysis within a community-based diabetes prevention project FIN-D2D. BMC Public Health. 12(1). 514–514. 16 indexed citations

10.

Lehto, Soili M., Anne Huotari, Leo Niskanen, et al.. (2010). Serum IL-7 and G-CSF in major depressive disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 34(6). 846–851. 32 indexed citations

11.

Astrup, Arne, et al.. (2009). Treatment with Liraglutide, a Once-Daily Human GLP-1 Analog, for 52 Weeks Reduces Weight and Waist Circumference: A Randomized Placebo-Controlled Trial. UCL Discovery (University College London). 1 indexed citations

12.

Astrup, Arne, Raffaele Carraro, Nick Finer, et al.. (2009). Tolerability and weight loss effects of liraglutide in obese adults: a 104-week randomised trial. UCL Discovery (University College London).

13.

Finer, Nick, Arne Astrup, Alex Harper, et al.. (2009). Liraglutide, a once-daily human GLP-1 analogue, reduces the prevalence of prediabetes in obese subjects over 20 weeks: a randomized placebo-controlled trial. UCL Discovery (University College London). 1 indexed citations

14.

Valtonen, Maija, et al.. (2005). Effect of melatonin-rich night-time milk on sleep and activity in elderly institutionalized subjects. Nordic Journal of Psychiatry. 59(3). 217–221. 57 indexed citations

15.

Carraro, Raffaele, Nick Finer, Marie Kunešová, et al.. (2003). 2003 William J. Stickel Silver Award. Skin temperatures as a one-time screening tool do not predict future diabetic foot complications. UCL Discovery (University College London). 2 indexed citations

16.

Niskanen, Leo, Markku Teräsvirta, Matti K. Karvonen, et al.. (2000). Leucine 7 to proline 7 polymorphism in the neuropeptide y gene is associated with retinopathy in Type 2 diabetes. Experimental and Clinical Endocrinology & Diabetes. 108(3). 235–236. 46 indexed citations

17.

Töyry, Jari, Juhani Partanen, Leo Niskanen, Esko Länsimies, & Matti Uusitupa. (1997). Divergent development of autonomic and peripheral somatic neuropathies in NIDDM. Diabetologia. 40(8). 953–958. 43 indexed citations

18.

Viinamäki, Heimo, Kaj Koskela, & Leo Niskanen. (1996). Rapidly declining mental well-being during unemployment. The European Journal of Psychiatry. 10(4). 215–221. 16 indexed citations

19.

Viinamäki, Heimo, Leo Niskanen, & Kaj Koskela. (1995). General health questionnaire and beck depression scale as screening methods for psychiatric morbidity among the unemployed.. The European Journal of Psychiatry. 9(4). 209–216. 7 indexed citations

20.

Riska, H., H Tukiainen, Matti Uusitupa, et al.. (1989). COMPARISON OF INTRAVENOUS ENPROFYLLINE AND THEOPHYLLINE IN THE TREATMENT OF ACUTE ASTHMA. Current Therapeutic Research. 45(5). 907–913. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact